Page last updated: 2024-10-31

neostigmine and Arteriosclerosis

neostigmine has been researched along with Arteriosclerosis in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kutty, KM1
Murphy, DM1
O'Donnell, J1
Chu, MI1

Other Studies

1 other study available for neostigmine and Arteriosclerosis

ArticleYear
Cholinesterase in the atherosclerotic intima and in fibroblast cultures.
    Experientia, 1979, Mar-15, Volume: 35, Issue:3

    Topics: Animals; Arteriosclerosis; Blood; Cells, Cultured; Cholesterol Esters; Cholinesterases; Culture Medi

1979